Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04284449
Other study ID # RB7102019
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 24, 2020
Est. completion date December 2023

Study information

Verified date March 2023
Source National University of Natural Medicine
Contact Ryan Bradley, ND
Phone 503.552.1804
Email rbradley@nunm.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An observational study to determine outcomes of older adults who are under naturopathic medical care for cognitive complaints at a specific clinic in Southern California.


Description:

This prospective observational study will examine patient outcomes associated with individualized, whole-system integrative medical care, provided by a naturopathic physician at a specific clinic in the state of California. Participants will be older adult patients of the clinic who present with objectively measurable cognitive dysfunction, and who elect to voluntarily participate in the study. Participants' cognitive function will be assessed using validated objective (NIH Toolbox) and subjective (NIH Neuro-Quality of Life questionnaires) instruments. The primary outcomes are change from baseline to six months post-baseline in these two instruments. Additionally, physical activity and sleep data will be tracked using wearable telemetry, and neurophysiological parameters will be measured with electroencephalography. Detailed treatment descriptions and adverse events will be tracked.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Community-dwelling adults =60 years of age. - Montreal Cognitive Assessment (MoCA) score of 12-23. - Able to independently make decisions. - Able to safely travel to North County Natural Medicine for 4 study visits and approximately 4 clinical visits, for a duration of 6 months. - Able to wear an Oura Ring, download data every 6 days, and keep the ring regularly charged for the duration of participants' involvement in the study. - A high school diploma or equivalent. - Ability to communicate via email. - Ability to independently fill out a computer-administered questionnaire. - Ability to withhold from seeing another integrative or alternative medicine provider for the 6 months of participation in the study. Exclusion Criteria: - Inability to read and write in English. - MoCA score >23. - A visual impairment that would prevent reading a computer screen. - Partial or full deafness. - A previous diagnosis of dementia (e.g. Alzheimer's Disease or any other kind of dementia). - Congenital cognitive impairment or disability. - Alcohol or substance abuse. - Serious somatic disease, neurodegenerative disease, acute onset of cognitive decline, or rapid neurological impairment. - Inability to bring an affiliate to the Informed Consent Consultation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Whole-practice cognitive optimization
This intervention is a whole-practice intervention that may include nutritional assessment & supplementation, determination of food sensitivities and dietary changes, natural products such as herbal anti-inflammatories, assessment of whole body-burden of toxicants (such as heavy metals and fungal toxins) and steps to reduce exposures, and behavioral changes such as exercise, meditation, and sleep hygiene optimization.

Locations

Country Name City State
United States North County Natural Medicine Encinitas California

Sponsors (2)

Lead Sponsor Collaborator
National University of Natural Medicine North County Natural Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary NIH Toolbox-Cognitive Battery Change from baseline to 6 months in scores on a computer-administered cognitive function test Baseline, 6 months
Primary Quality of Life in Neurological Disorders questionnaire (Neuro-QoL) Change from baseline to 6 months in scores on a brief, validated questionnaire that monitors the physical, mental, and social effects experienced by individuals living with neurological conditions Baseline, 6 months
Secondary Event-related potential (P300) Change from baseline to 6 months of an auditory event provoked change in electrical potential of the brain, measured noninvasively by electroencephalography (EEG) 6 months post-baseline visit
Secondary Peak alpha frequency Change from baseline to 6 months of the peak (highest intensity) frequency in electrical activity of the brain between 8 Hz and 12 Hz, measured noninvasively by electroencephalography (EEG) 6 months post-baseline visit
Secondary Physical activity Change from baseline to 6 months in participants' overall physical activity as measured with telemetry from a wrist-worn activity tracker 6 months
Secondary Sleep quantity Change from baseline to 6 months in participants' total sleep as measured with telemetry from a wrist-worn activity tracker 6 months
Secondary Number and type of Adverse Events Total number of adverse events and serious adverse events (using NIH's Common Terminology Criteria for Adverse Events version 4.0) From enrollment through study completion, a period of 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05273125 - MOBility Disorders Assessment in Patients With Mild COGnitive Disorders
Active, not recruiting NCT04049695 - Improving Cognition After Cancer N/A
Completed NCT05912374 - Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs N/A
Recruiting NCT03977350 - Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)
Not yet recruiting NCT06027632 - Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer N/A
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Completed NCT00719628 - Depth of Anaesthesia and Cognitive Dysfunction N/A
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed NCT04966455 - Effect of Raisins on Cognitive Function in Healthy Older Adults Phase 3
Recruiting NCT05372159 - Vanderbilt Memory and Aging Project
Completed NCT03243279 - BRS and Outcomes in Cardiothoracic Surgery
Completed NCT04093882 - The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
Recruiting NCT05732285 - A Pilot Randomized Controlled Trial: CoINTEGRATE N/A
Completed NCT06059768 - Urdu Translation and Psychometric Analysis of Lawton IADLS.
Completed NCT04562662 - Evaluation of mediVR-KAGURA Guided Therapy N/A
Completed NCT04624529 - Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke
Not yet recruiting NCT04079075 - Multiple Interventions to Prevent Cognitive Decline N/A
Active, not recruiting NCT04638101 - Building the Path to Resilience in Preterm Infants: Mindfulness-based Intervention N/A
Active, not recruiting NCT04556305 - Lifestyle Physical Activity and Cognitive Training Interventions N/A